SEC Form 4 · accession 0001232524-15-000044
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey K Tobias
Officer — EVP, R&D & CMO
Period of report
Feb 26, 2015
Accepted (ET)
Mar 2, 2015 · 6:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 26, 2015 | A | 5,755 | $0.00 | A | 40,818 | D | |
| Ordinary Shares | Feb 27, 2015 | F | 704 | $170.09 | D | 40,114 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F3 | $175.19 | Feb 26, 2015 | A | 570 | A | — | Feb 25, 2025 | Ordinary Shares | 570 | 570 | D |
| Non-Qualified Stock Option (right to buy)F3 | $175.19 | Feb 26, 2015 | A | 14,430 | A | — | Feb 25, 2025 | Ordinary Shares | 14,430 | 14,430 | D |
Explanation of responses
- F1These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, February 26, 2015.
- F2Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F3These two options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these two options vest over four years measured from the grant date, February 26, 2015, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.